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Abstract: Background: Cardiopulmonary fitness and low calorie diets have been shown to reduce
inflammation but few studies have been conducted in individuals with elevated blood pressure (BP) in
a randomized intervention setting. Thereby, adhesion biomarkers, e.g., soluble intercellular adhesion
molecule (sICAM)-3, have not been examined so far. Methods: Sixty-eight sedentary prehypertensive
and mildly hypertensive individuals (mean age ± SEM: 45 ± 1 years; mean BP: 141/84 ± 1/1 mmHg)
were randomized to one of three 12-week intervention groups: cardio training and caloric reduction,
cardio training alone, or wait-list control group. Plasma levels of inflammatory, adhesion and
prothrombotic biomarkers were assessed. In a second step, intervention groups were combined to
one sample and multivariate regression analyses were applied in order to account for exercise and
diet behavior changes. Results: There were no significant differences among the intervention groups.
In the combined sample, greater caloric reduction was associated with a larger increase of sICAM-3
(p = 0.026) and decrease of C-reactive protein (p = 0.018) as a result of the interventions. More cardio
training was associated with increases of sICAM-3 (p = 0.046) as well as interleukin-6 (p = 0.004) and
a decrease of tumor necrosis factor-α (p = 0.017) levels. Higher BP predicted higher plasminogen
activator inhibitor (PAI)-1 (p = 0.001), and greater fitness predicted lower PAI-1 levels (p = 0.006) after
the intervention. Conclusions: In prehypertensive and hypertensive patients, plasma levels of the
adhesion molecule sICAM-3 and inflammatory biomarkers have different response patterns to cardio
training with and without caloric reduction. Such anti-inflammatory and anti-thrombotic effects may
have implications for the prevention of atherothrombotic cardiovascular disease among individuals
at increased risk.
Keywords: hypertension; prehypertension; exercise; diet; adhesion molecule; sICAM; soluble
intercellular adhesion molecule; inflammatory markers; intervention
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1. Introduction
The pathogenesis of hypertension seems to be more complex, as it is difficult to treat despite
established antihypertensive drugs and longtime cardiovascular research. Hypertension (blood pressure
(BP)≥ 140/90 mmHg) is a highly prevalent disease among United States (U.S.) citizens with a well-known
impact on numerous comorbid conditions and public-health related outcomes [1–3]. On a cellular level,
it is established knowledge that individuals with hypertension exhibit elevated blood levels of cellular
adhesion molecules [4–6] as well as inflammatory markers [7–15]. The reason for that is mainly seen in
endothelial activation [12], which explains the tight linkage between elevated BP, chronic inflammatory
processes including atherosclerosis and adverse health related outcomes [7,16]. So far, studies on the
effects of human hypertension on adhesion molecules have been focusing on soluble intercellular
adhesion molecule-1 (sICAM-1; sCD54) [4–6] while studies measuring sICAM-3, which is potentially
much more important for immune response [17], are scarce.
In treating hypertension, lifestyle modifications including adopting a regular exercise regimen
are key constituents of treatment [18,19]. This recommendation might also apply to prehypertension
(BP > 120/80 and<140/90 mmHg), a risk factor for the development of hypertension. The effect achieved
depends on both intensity and frequency of exercise [20–22], and BP reductions of up to 15 mmHg can
be achieved without using antihypertensive drugs and thus avoiding their common side effects [23].
In overweight hypertensive subjects, a combined exercise and dietary weight-loss intervention was
shown to lead to even greater reductions in BP than exercise alone [22].
Meanwhile, few studies have examined the relationship between exercise and inflammation
in hypertensive patients. One of the few studies showed that exercise and/or exercise plus diet
interventions lead to reductions in circulating interleukin (IL)-6 and C-reactive protein (CRP) levels in
obese individuals [24]. In normotensive, healthy individuals, cross-sectional epidemiological studies
have shown physical activity to be negatively associated with CRP, fibrinogen, and white blood
cell count [25] and inflammatory markers, including tumor necrosis factor (TNF)-α and IL-6 and
prothrombotic plasminogen activator inhibitor (PAI-1) were shown to be inversely related to physical
activity levels [26–28]. Furthermore, our group has shown that physical activity level and fitness are
inversely related to leukocyte adhesion molecule expression [29,30].
Guided by the above described effects observed in healthy individuals, the purpose of this study
was to explore the relationship of a 12-week exercise (and diet) intervention and inflammation/cell
adhesion in patients with prehypertension and hypertension by measuring circulating levels of CRP,
IL-6, TNF-α, PAI-1, and sICAM-1 and sICAM-3 by taking relevant cardio-metabolic confounding
factors (body mass index (BMI), physical inactivity) into account. Based on these data of a randomized
controlled trial (RCT), our aim was to show for the first time in vivo that exercise has not only an impact
on levels of inflammatory biomarkers, but also on levels of cellular adhesion molecules. Our main
hypothesis was that, compared to a 12-week wait-list control group, the 12-week exercise intervention,
and especially the 12-week exercise plus diet intervention, would result in greater reduction of
inflammatory biomarkers and cell adhesion molecules pre to post intervention. Second, we expected
that both intervention groups would show increased fitness levels and greater BP reduction and weight
reduction as compared to the wait-list control group.
2. Methods
2.1. Ethical Approval and Informed Consent
Data is taken from a clinical trial on the effects of exercise and diet on inflammation in
hypertensive individuals registered in a public registry (www.clinicaltrials.gov, ClinicalTrials.gov
Identifier: NCT00338572). The University of California San Diego (UCSD) Institutional Review Board
approved the study protocol, to which all participants signed a written informed consent. All procedures
performed in studies involving human participants were in accordance with the ethical standards of
the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later
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amendments or comparable ethical standards. Participants were recruited from the local community
through flyers, referrals from local doctor’s offices and e-mail list serve distribution.
2.2. Data Source, Effect of Exercise and Diet on Inflammation in Hypertensive Individuals Trial
The data of the present secondary analysis is derived from a prospective, randomized controlled
intervention study examining the effect of exercise and diet on inflammation in hypertensive individuals.
That study was conducted in order to compare the effect of an exercise program versus a combined
exercise and diet program on reducing inflammation in hypertensive individuals. Figure 1 shows the
RCT CONSORT flow diagram for participants. Of 168 eligible people, 77 individuals chose not to enter
the RCT. The 91 remaining participants were randomly assigned to one of three 12-week intervention
groups: aerobic cardio training and caloric reduction, aerobic cardio training alone, or wait-list control
group. Participants assigned to the wait-list group were controls for at least 12 weeks until they were
allocated to one of the intervention groups (exercise alone or exercise plus “Dietary Approaches to
Stop Hypertension” (DASH) group). Of these 91 subjects, 9 individuals did not complete the study
for personal reasons, moving away from San Diego (n = 2), becoming too busy or starting a new
job (n = 5), becoming ill (n = 2, colon rupture, neurological concerns), and 14 individuals were not
reliable/cancelled.
m local doctor’s offices and e
“ ”
hypertension (≥140/90 but <180/110 mmHg)
Figure 1. CONSORT flow diagram for participants.
The trial included relatively healthy, sedentary and non-medicated men and women (n = 91)
between age 18 and 65 years with prehypertension (>120/80 but <140/90 mmHg) and stage 1 and
2 hypertension (≥140/90 but <180/110 mmHg), who were not on a current diet or had been participating
in an exercise program within the past 6 months. The level of habitual physical activity was assessed
using the Leisure Time Exercise Questionnaire (LTEQ) by Godin and Shepard [31] to confirm the
sedentary status; individuals with LTEQ total scores above 40 were excluded. Major concomitant
diseases were ruled out by blood sample, resting electrocardiogram and medical history. For each
eligible participant, a trained technician or registered nurse obtained anthropometric data through
standard procedures. Body weight, height and average resting BP (six measurements taken after a
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15-min seated rest on two separate days using a Dinamap Compact BP® monitor (Critikon, Tempa,
FL, USA)). Participants with values of high-sensitivity CRP >10 mg/L were excluded from the analyses,
as values above this threshold are indicative of an acute infection.
2.3. Fitness Testing
Participants underwent a maximum oxygen intake (VO2peak, mL/kg/min) treadmill exercise test
to determine cardiorespiratory fitness using the standard Bruce protocol in which treadmill speed and
grade were increased gradually from 1.7 mph and 10% grade every 3 min. Expired gas was analyzed
by Sensormedics metabolic cart, Milano, Italy (Vmax software version 6-2A).
2.4. Aerobic Cardio Training
Since all participants were relatively sedentary at baseline, the training intervention was designed
to increase exercise levels gradually to the ultimate physical activity goal: Five or more days per week
of at least moderate-intensity cardiovascular physical activity (e.g., walking) for 30 to 60 min. Exercise
intensity was individually adapted by the assessed heart rate (before and during exercise). Participants
met with a certified personal trainer (study personnel) at the local YMCA 2 days a week for the entire
12-week intervention period. They shared with the trainer the fitness information. In-person sessions
with a trainer were scheduled, as they are more likely to be completed than entirely home-based
exercise and may increase the motivation for completion of the three sessions per week of exercise
without a personal trainer. The sessions with the trainer included training in proper warm up, exercise
and cool down and stretching. The participant was asked to do physical activity on his or her own
(either in their home, neighborhood or at the YMCA) for three additional days per week. In addition
to meeting a goal for the number of minutes of physical activity, participants were asked to increase
incidental physical activity. To monitor their progress, participants were given a pedometer and asked
to work up to an ultimate goal of an average of 10,000+ steps per day. We used the same pedometer
(Omron®, Kyōto, Japan) throughout the study to warrant an adequate comparison. The inclusion of
the pedometer and step goal helped to ensure that participants were not compensating for increased
activity during their sessions with the personal trainer by being more sedentary throughout the rest of
the day. The achievement of these goals ensured an increase in energy expenditure, which contributed
to a negative energy balance. Subjects completed a log of their daily pedometer readings and presented
them to the trainer each week.
2.5. Caloric Reduction
The dietary intervention was led by research dietitians at the Nutrition Services Core of the
UCSD Medical Center General Clinical Research Center (GCRC) or Clinical and Translational Research
Institute (CTRI). The core of the diet plan was based on the DASH clinical study [32,33]. This dietary
pattern is high in fruits, vegetables, and low fat dairy foods, and low in saturated and total fat.
It also is high in dietary fiber, potassium, calcium, and magnesium, and moderately high in protein.
The dietary intervention aimed at reducing the individual energy intake by 500–1000 kcal/day taking
into account lifestyle and dietary preferences of the participant [34]. In addition, concomitant behavioral
strategies like conscious eating and stimulus control were trained. Thus, participants received intensive
intervention approaches known to produce behavior change. Subjects in the experimental group met
with registered dietitians and/or certified exercise trainers to establish initial dietary and physical
activity goals. Regular meetings in person and by phone continued for the entire 12-week intervention.
All subjects recorded their food (caloric intake in kilojoule) and provided the information to the
study investigators. Diet adherence was assessed with three daily dietary recalls administered by the
study dietician.
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2.6. Assessment of Inflammatory Biomarkers and Cellular Adhesion Molecules
Fasting blood samples were collected within one week of, but at least two days after, the maximum
exercise test at baseline. All assays were performed in the UCSD Clinical Research Biomarker Laboratory
using commercially available immunoassay kits (R&D Systems products, Minneapolis, MN, or MSD
Systems, Rockville, MD, USA). Intra- and inter-assay coefficients of variation (CV) were confirmed to
be <5%. For subsequent statistical analyses, soluble ICAM-1 (sample size, 63), sICAM-3 (66), PAI-1 (68),
CRP (62), IL-6 (65), and TNF-α (63) measures were log-transformed to normalize distributions with
differing sample sizes reflecting missing biomarker data due to technical errors, etc., and we calculated
the difference (∆) from pre to post intervention levels for all biomarker measures by detracting the
value before the intervention from the value after the intervention.
2.7. Secondary Analysis of Trial Data
According to the RCT protocol, n = 18 had been to the aerobic cardio training and caloric reduction
intervention, n = 28 to the aerobic cardio training alone intervention and n = 22 to the wait-list control
group. However, in reality, participants began modifying their exercise or diet behavior regardless
of their intervention group assignment and modest group sizes limited statistical power. Therefore,
we decided for a statistical approach with a secondary analysis of data from all 68 participants combined
that may better warrant to indicate the actual behavior and inflammatory processes and consider the
intervention effect described respectively.
Thus, a series of multivariate linear regression analyses were performed to examine the role
of the different intervention elements (predictors). For the three predictors fitness, cardio training,
and caloric intake, the differences (∆) from pre to post intervention levels were used in the statistical
analyses. We calculated these differences (∆) by detracting the value before the intervention from the
value after the intervention. Associations between the four predictors (BP, fitness, cardio training,
and caloric intake) and outcomes (differences (∆) from pre to post intervention levels of cellular
adhesion molecules (sICAM-1, sICAM-3) and inflammatory biomarkers (CRP, IL-6, TNF-α)) were
determined using multiple linear regression models, separately for each of the five outcome variables.
Results were considered statistically significant at p ≤ 0.05. We did not adjust p-values for multiple
comparisons, as the main primary outcome was CRP; however, as we examined the potential interaction
among inflammatory, adhesion and prothrombic markers, we defined one primary outcome marker in
each of these three biomarker domains playing different roles in CVD: CRP for inflammation, sICAM-1
for adhesion molecules, and PAI-1 for prothrombotic factors. All other outcomes (IL-6, TNF, sICAM-3)
were secondary (Il-6 and TNF) or exploratory (sICAM-3, as no study so far has been investigating
sICAM-3).
For the associations between each of the predictors and inflammatory marker outcome levels,
two models of increasing complexity were computed: in Model 1 we adjusted for (prehypertensive or
hypertensive) BP and sociodemographic factors (age, gender) only, and in Model 2 we additionally
adjusted for the other remaining predictors in one complete regression model (Table 1). Only the
significant results of the five statistical models are shown for a better overview (Table 1). For our
second hypothesis, mean pre and post intervention BP, fitness levels, and weight of the three groups
were compared to each other. All statistical analyses were performed using IBM® SPSS® version 22.0
statistical software package (IBM Corporation, New York, NY, USA).
Table 1. First step a and final b multivariate regression analyses between inflammatory biomarkers and
intervention elements (predictors) in the studied pre- and hypertensive participants.
Predictor ∆ c Outcome d β p e
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a The first step regression model included predictor, age, gender, and the difference from pre to post intervention
biomarker level, and systolic blood pressure (except for systolic blood pressure as predictor). b The final model
included the first step model and additionally the other predictors, and the difference from pre to post intervention
body mass index level. c ∆, value difference from pre to post intervention level: We calculated the difference from
pre to post intervention levels by detracting the value before the intervention from the value after the intervention.
d PAI, plasminogen activator inhibitor; sICAM, soluble intercellular adhesion molecule; CRP, C-reactive protein; IL,
interleukin; TNF-α, tumor necrosis factor-alpha. e SBP, systolic blood pressure. f Cardio training, moderate aerobic
cardio training: total minutes during 12-week-intervention. e p < 0.05.
3. Results
3.1. Study Sample
The baseline demographic, metabolic and health behavior characteristics of all study participants
(n = 68) included in the statistical analyses are displayed in Table 2. In the combined 68 participants,
22 subjects had reduced caloric intake and exercised regularly. These 22 participants had an average
daily caloric reduction of 673 ± 594 calories (mean ± SEM) and had on average exercised 22.9 ± 2.8 h
during the 12-week intervention (on average 114.5 ± 14 min per week). The intensity of aerobic cardio
training of the hypertensive patients did not differ significantly from that of the prehypertensive
patients (p = 0.18). Subjects who exercised regularly but had no caloric reduction (n = 38) had spent on
average 21.1 ± 2.0 h on training during the 12-week intervention (on average 105.5 ± 10 min per week).
Thirteen % of the participants were current smokers based on self-report.
Table 2. Demographic, metabolic and health behavior characteristics of the study participants before
the intervention.
Variable n a
Mean ± SEM and Range in
Parentheses or Percentage Value
Prehypertension/Hypertension 68 44.1%/55.9%
Systolic blood pressure, mmHg 68 141 ± 1 (124–174)
Diastolic blood pressure, mmHg 68 84 ± 1 (69–102)
Heart rate, beats/min 68 75 ± 1 (53.0–99)
Age, years 68 45 ± 1 (25–60)
Gender, male/female 68 45%/55%
Body mass index, kg/m2 67 30.8 ± 0.5 (22.4–38.8)
Glucose, mg/dL 64 89 ± 1 (59–120)
Total cholesterol/HDL-cholesterol ratio 63 4.8 ± 0.2 (0.5–10.8)
Smoking 68 13%
Concomitant medication 68 0%
Leisure time exercise questionnaire 65 11.7 ± 1.2 (0.0–35.0)
VO2peak
b (mL/kg/min) 68 27.9 ± 0.9 (15.0–54.0)
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Table 2. Cont.
Variable n a
Mean ± SEM and Range in
Parentheses or Percentage Value
Inflammatory measures before the intervention n c
C-reactive protein, mg/L 63 2.8 (1.1–7.1)
Interleukin-6, pg/mL 66 2.7 (1.2–4.3)
Tumor necrosis factor-α, pg/mL 68 2.7 (1.2–4.1)
Plasminogen activator inhibitor-1, ng/mL 62 41.1 (21.4–61.2)
Soluble intercellular adhesion molecule-1, ng/mL 65 306.8 (239.3–374.1)
Soluble intercellular adhesion molecule-3, ng/mL 63 2.6 (2.2–3.2)
Data are given as mean ± standard error of the mean (SEM) (range) or percentage values. Inflammatory measures
are given as medians (interquartile range). a n, number of subjects included. b VO2peak, peak oxygen consumption.
c n, number of subjects who provided biomarker’s measurement before and after the intervention.
3.2. Blood Pressure Classification before and after Intervention
After the intervention the mean SBP reduction for hypertensive subjects (n = 34) with
10.1 ± 2.6 mmHg was greater than the prehypertensive subjects (n = 25) with 4.4 ± 1.3 mmHg
but not significantly so (p = 0.06). However, the average SBP of the hypertensive patients (n = 34;
mean ± SEM: 148.1 ± 1.6 mmHg) decreased to the prehypertensive level of 137.9 ± 2.3 mmHg.
3.3. Cellular Adhesion Molecules and Inflammatory Biomarker Associations with Elevated Blood Pressure,
Fitness and Obesity in the 68 Participants
We calculated Pearson’s correlations to examine the associations of the soluble intercellular
adhesion molecules and inflammatory biomarkers with BP, BMI, and fitness before the intervention.
CRP was negatively correlated with fitness (r = −0.308; p < 0.05) and positively with BMI (r = 0.327;
p < 0.01). IL-6 was negatively associated with fitness (r = −0.311; p < 0.05) and positively associated
with SBP (r = 0.310; p < 0.05). TNF-α was negatively correlated with SBP (r = −0.364; p < 0.01).
Soluble ICAM-1 was negatively associated with fitness (r = −0.242; p < 0.05) and was positively
associated with CRP (r = 0.414; p < 0.01) but not with BP. Soluble ICAM-3 had no associations with BP,
BMI, fitness or sICAM-1.
3.4. Behavioral Change by Intervention Elements, Change of BMI and Fitness and Its Role in Inflammation in
All Participants with Elevated Blood Pressures
The higher the SBP the higher were PAI-1 levels (β = 0.427; p = 0.001), and the more the fitness
level had improved during the intervention the lower were PAI-1 levels (β = −0.392; p < 0.01) after the
intervention (Table 1). Aerobic cardio training was a significant independent predictor of sICAM-3, IL-6,
and TNF-α levels after controlling for sociodemographic variables and SBP in a first step regression
model (Table 1), meaning the greater the amount of total moderate exercise was, the higher were the
levels of sICAM-3 and IL-6, and the lower were the levels of TNF-α (Table 1) after the intervention.
From earlier analyses [35,36], BMI decreased in the exercise groups, and fitness increased in those
groups. These results remained statistically significant, even after adjusting for changes in BMI, fitness,
and caloric reduction in the final model (sICAM-3 (β = 0.301; p < 0.05), IL-6 (β = 0.415; p < 0.01),
and TNF-α (β = −0.357; p < 0.05); Table 1). Caloric reduction (to reduce caloric intake) predicted
significantly higher sICAM-3 (β = −0.332; p < 0.05) and lower CRP (β = 0.342; p < 0.05) levels in the
first step and final model (Table 1).
4. Discussion
We examined the differential effects of aerobic cardio training and caloric reduction on
inflammatory, adhesion and prothrombotic biomarkers in prehypertensive and hypertensive subjects.
Our study adds to the existent body of literature in the context of behavioral (aerobic exercise and
diet) intervention and hypertension for inflammatory biomarker outcomes. The more comprehensive
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approach of lifestyle changes including exercise and diet behavior change of this 12-week-intervention
study might explain the differential changes of inflammatory (CRP, IL-6, TNF-α) and prothrombotic
(PAI-1), and adhesion (sICAM-1 and -3) biomarkers.
The key finding is that aerobic cardio training and/or caloric reduction had differential effects
on IL-6 and adhesion molecule sICAM-3 in vivo. In particular, the latter finding is novel showing
a prospective association between exercise and caloric reduction respectively and sICAM-3 levels.
Thereby, this is the first study to our knowledge that shows that aerobic exercise has not only an
impact on inflammatory biomarkers but also on levels of cellular adhesion molecules. Until now,
it was unclear how they might interact, although it is well known that aerobic exercise reduces
inflammatory processes.
The increase of sICAM-3 and IL-6 in subjects with elevated BP was independently predicted by
the intensity of aerobic cardio training and caloric reduction. We think that this finding may be initially
counter-intuitive but is important for the following reasons: First, this finding is consistent with prior
studies, which showed that exercise was associated with a significant increase in IL-6 [37,38]. In this
study, however, increased IL-6 levels after intervention and its positive correlation with both exercise
levels and caloric reduction may be explained by potentially anti-inflammatory effects of IL-6 [39]. IL-6 is
a pleiotropic cytokine released by skeletal myocytes under contraction, mediating anti-inflammatory
effects by stimulating the production of anti-inflammatory cytokines and suppression of TNF-α
production [39] with all these mechanisms concurring with the results of this study. Second, this is the
first study to highlight the potential role of sICAM-3 in vascular inflammatory effects of exercise and/or
diet intervention among prehypertensive and hypertensive subjects. To date, studies on the effects of
human hypertension on adhesion molecules have been focusing on sICAM-1 levels, which are increased
in hypertensive individuals [4–6]. Soluble ICAM-1 levels reflect ICAM-1 expression on activated
endothelial cells [40] and are associated with the degree of atherosclerosis [41]. Although ICAM-1 and
ICAM-3 share a similar immunoglobulin-like structure and amino acid identity of about 48%, with the
greatest homology observed in domains 2 and 3 [42], their differential pattern of expression and cellular
distribution suggest a different functional role [42]. The interactions of ICAM-1 and ICAM-3 with
lymphocyte function-associated antigen (LFA)-1 are integral to the normal functioning of the immune
system [42]. ICAM-3 is expressed on resting leucocytes and is potentially the most important ligand for
LFA-1 in the initiation of the immune response because the expression of ICAM-1 on resting leucocytes
is low [17]. Although sICAM-3 binds to LFA-1 with an affinity approximately nine-times weaker
than sICAM-1, sICAM-1 and sICAM-3 compete with each other for binding to LFA-1 [42]. As we did
not find changes in sICAM-1 levels post interventions in this study, we speculate that the increase
in sICAM-3 levels as a result of changes in exercise and/or diet behavior in this study may exhibit
a “buffer” for the sICAM-1 function, potentially leading to down-regulating vascular endothelial
inflammation. It is not fully understood whether the increase of sICAM-3 by cardio training and
caloric reduction in prehypertensive and hypertensive subjects reflects a cardio-protective mechanism.
Given the lack of knowledge in the vascular function of sICAM-3 and its implications as a vascular
inflammatory biomarker, a follow-up investigation is necessary to examine its vascular action and
interactions separate of or in conjunction with other better-known vascular endothelial markers such
as sICAM-1.
Another relevant potential underlying pathway in hypertension, metabolic syndrome,
dyslipidaemia, and abdominal obesity, is the dysregulation of the hypothalamic–pituitary–adrenal
(HPA) axis leading to catecholamine activation of β-adrenergic receptors (β-ARs) [43]. This may
lead to altered leukocyte/endothelial binding, endothelial injury with up-regulation of endothelial
ICAM-1 expression and increase of inflammatory cytokines [44]. In this context, regular aerobic exercise
has also been shown to enhance β-AR sensitivity in the context of age-related decline in adrenergic
responsiveness, i.e., increase of total peripheral resistances, which is a relevant factor underlying
hypertension, atherosclerosis, and vascular insufficiency [45,46].
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This study has a number of limitations. First, a weakness of the experimental design of this
study is the lack of healthy BP controls. Thus, we are unable to determine whether the inflammatory,
adhesion, and prothrombotic factors measured were indeed elevated in our sample of individuals with
hypertension and prehypertension as compared with healthy individuals, and whether the changes
induced by diet and exercise in these factors are at the level of clinical benefits. Second, a randomized
and controlled trial of 12-week intervention of health behavior change was proven challenging
and resulted in modest group sizes, limiting statistical power. More importantly, few significant
differences found among intervention groups led us to scrutinize the actual changes in exercise and
diet behavior. In reality, in spite of our best efforts to avoid “cross-contamination” between health
behaviors, participants naturally began modifying their exercise or diet behavior regardless of their
intervention group assignment. Some participants assigned to wait-list control condition also began
to change their health behavior. Although troubling for behavior intervention trials, this kind of
behavior is not particularly surprising, as exercise and healthy diet behaviors tend to co-occur [47].
It was revealed also particularly challenging to prohibit study volunteers who exhibit “readiness”
to change their health behavior from doing so to follow randomization to a wait-list control group
in a trial such as this. Therefore, as aforementioned, we collapsed all groups into one sample and
applied multivariate regression analyses to the whole sample in order to account for exercise and diet
behavior changes in practice during the intervention period. Third, regarding the dietary intervention,
we have to mention that we did not differ short supply chain (SSC) from long supply chain (LSC) food
included in the DASH [48]. A recent cross-sectional study found that only individuals adhering to
the Mediterranean diet with an SSC had a significantly reduced prevalence of metabolic syndrome
compared to those with an LSC [48]. Further, recent studies have shown that inflammatory effects
of food parameters exist with a high variability [49] due to either a different genetic pattern or to
diverse genetic–environmental interactions, and potential interactions (synergism, antagonism) among
food parameters. However, as previously proposed, such a “dietary inflammatory index” ought to be
advanced further [49]. Another intervention group, diet alone, may have contributed to important
additional information. Fourth, our study did not explore the role of gender in the potentially differing
effects of exercise and/or diet on inflammatory or prothrombotic markers, which was beside the primary
aim of the study and limited by a limited sample size. Future studies should investigate the effect of
gender not only on the intervention effects but also such behavior changes.
In summary, regular exercise and caloric reduction in individuals at risk of essential hypertension
may have differential effects on biomarkers of CVD risk which may have clinical implications for the
prevention of atherothrombotic cardiovascular disease. Assessments of the actual behavioral changes
above and beyond intervention group assignment appear to be important. Nonetheless, the evidence
of beneficial effects of regular physical activity on CV health and prevention of CVD risk, including BP,
lipid levels and glucose tolerance [50] needs to be highlighted.
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